U.S. multicenter pilot study of daily consensus interferon (CIFN) plus ribavirin for "difficult-to-treat" HCV genotype 1 patients

Samuel B. Ho, Bashar Aqel, Eric Dieperink, Shanglei Liu, Lori Tetrick, Yngve Falck-Ytter, Charles Decomarmond, Coleman I. Smith, Daniel P. McKee, William Boyd, Clark C. Kulig, Edmund J. Bini, Marcos C. Pedrosa

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Fingerprint Dive into the research topics of 'U.S. multicenter pilot study of daily consensus interferon (CIFN) plus ribavirin for "difficult-to-treat" HCV genotype 1 patients'. Together they form a unique fingerprint.

Medicine & Life Sciences